Tuesday, November 5
Shadow

Investigation Finds Widespread Rule-Breaking in Reporting of U.S. Clinical Trials

Investigation Finds Widespread Rule-Breaking in Reporting of U.S. Clinical Trials
zyaivcdlpniimkse2fp1

zyaivcdlpniimkse2fp1

Universities, drug companies, and government agencies are breaking the law and not turning in their science homework, according to a new report out Monday. It shows that many of these entities aren’t reporting the results of their research to the government’s database of clinical trials as legally mandated, while the…

Read more…

Go to Source

Exit mobile version